Literature DB >> 17931458

Gene expression profiling of Leishmania (Leishmania) donovani: overcoming technical variation and exploiting biological variation.

S Decuypere1, M Vanaerschot, S Rijal, V Yardley, L Maes, S de Doncker, F Chappuis, J-C Dujardin.   

Abstract

Gene expression profiling is increasingly used in the field of infectious diseases for characterization of host, pathogen and the nature of their interaction. The purpose of this study was to develop a robust, standardized method for comparative expression profiling and molecular characterization of Leishmania donovani clinical isolates. The limitations and possibilities associated with expression profiling in intracellular amastigotes and promastigotes were assessed through a series of comparative experiments in which technical and biological parameters were scrutinized. On a technical level, our results show that it is essential to use parasite harvesting procedures that involve minimal disturbance of the parasite's environment in order to 'freeze' gene expression levels instantly; this is particularly a delicate task for intracellular amastigotes and for specific 'sensory' genes. On the biological level, we demonstrate that gene expression levels fluctuate during in vitro development of both intracellular amastigotes and promastigotes. We chose to use expression-curves rather than single, specific, time-point measurements to capture this biological variation. Intracellular amastigote protocols need further refinement, but we describe a first generation tool for high-throughput comparative molecular characterization of patients' isolates, based on the changing expression profiles of promastigotes during in vitro differentiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17931458     DOI: 10.1017/S0031182007003782

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  11 in total

1.  Biomarkers of antimony resistance: need for expression analysis of multiple genes to distinguish resistance phenotype in clinical isolates of Leishmania donovani.

Authors:  Dhiraj Kumar; Ruchi Singh; Vasundhra Bhandari; Arpita Kulshrestha; Narendra Singh Negi; Poonam Salotra
Journal:  Parasitol Res       Date:  2012-07       Impact factor: 2.289

2.  Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance.

Authors:  Tim Downing; Hideo Imamura; Saskia Decuypere; Taane G Clark; Graham H Coombs; James A Cotton; James D Hilley; Simonne de Doncker; Ilse Maes; Jeremy C Mottram; Mike A Quail; Suman Rijal; Mandy Sanders; Gabriele Schönian; Olivia Stark; Shyam Sundar; Manu Vanaerschot; Christiane Hertz-Fowler; Jean-Claude Dujardin; Matthew Berriman
Journal:  Genome Res       Date:  2011-10-28       Impact factor: 9.043

3.  Elucidation of cellular mechanisms involved in experimental paromomycin resistance in Leishmania donovani.

Authors:  Vasundhra Bhandari; Shyam Sundar; Jean Claude Dujardin; Poonam Salotra
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

4.  Comparative gene expression analysis throughout the life cycle of Leishmania braziliensis: diversity of expression profiles among clinical isolates.

Authors:  Vanessa Adaui; Denis Castillo; Mirko Zimic; Andres Gutierrez; Saskia Decuypere; Manu Vanaerschot; Simonne De Doncker; Kathy Schnorbusch; Ilse Maes; Gert Van der Auwera; Louis Maes; Alejandro Llanos-Cuentas; Jorge Arevalo; Jean-Claude Dujardin
Journal:  PLoS Negl Trop Dis       Date:  2011-05-10

5.  Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background.

Authors:  Saskia Decuypere; Manu Vanaerschot; Kirstyn Brunker; Hideo Imamura; Sylke Müller; Basudha Khanal; Suman Rijal; Jean-Claude Dujardin; Graham H Coombs
Journal:  PLoS Negl Trop Dis       Date:  2012-02-28

Review 6.  LC-MS metabolomics from study design to data-analysis - using a versatile pathogen as a test case.

Authors:  Maya Berg; Manu Vanaerschot; Andris Jankevics; Bart Cuypers; Rainer Breitling; Jean-Claude Dujardin
Journal:  Comput Struct Biotechnol J       Date:  2013-02-06       Impact factor: 7.271

7.  Transcriptome profiling identifies genes/pathways associated with experimental resistance to paromomycin in Leishmania donovani.

Authors:  Aditya Verma; Vasundhra Bhandari; Deepak Kumar Deep; Shyam Sundar; Jean Claude Dujardin; Ruchi Singh; Poonam Salotra
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-10-10       Impact factor: 4.077

8.  Macromolecular biosynthetic parameters and metabolic profile in different life stages of Leishmania braziliensis: Amastigotes as a functionally less active stage.

Authors:  Marlene Jara; Maya Berg; Guy Caljon; Geraldine de Muylder; Bart Cuypers; Denis Castillo; Ilse Maes; María Del Carmen Orozco; Manu Vanaerschot; Jean-Claude Dujardin; Jorge Arevalo
Journal:  PLoS One       Date:  2017-07-25       Impact factor: 3.240

9.  Molecular Preadaptation to Antimony Resistance in Leishmania donovani on the Indian Subcontinent.

Authors:  F Dumetz; B Cuypers; H Imamura; D Zander; E D'Haenens; I Maes; M A Domagalska; J Clos; J-C Dujardin; G De Muylder
Journal:  mSphere       Date:  2018-04-18       Impact factor: 4.389

10.  Role of efflux pumps and intracellular thiols in natural antimony resistant isolates of Leishmania donovani.

Authors:  Smita Rai; Sudhir K Goel; Upendra Nath Dwivedi; Shyam Sundar; Neena Goyal
Journal:  PLoS One       Date:  2013-09-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.